<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3201">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01945801</url>
  </required_header>
  <id_info>
    <org_study_id>GPPG-13-0272</org_study_id>
    <secondary_id>13-0272</secondary_id>
    <nct_id>NCT01945801</nct_id>
  </id_info>
  <brief_title>Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea</brief_title>
  <acronym>DESALT</acronym>
  <official_title>The Effect of Sodium-Restricted Diet and Diuretic in the Severe Sleep Apnea: a Randomized Controlled Trial - DESALT Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare the effect of a low sodium diet to the diuretic in patients with severe obstructive
      sleep apnea.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Apnea-Hypopnea Index</measure>
    <time_frame>One week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of apneas/hour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Somnolence scale (Epworth) and ventilatory parameters</measure>
    <time_frame>One week</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid profile</measure>
    <time_frame>One week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total and HDL Cholesterol, Triglycerides,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aldosterone-Renin and sodium and potassium balance</measure>
    <time_frame>One week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Serum Aldosterone, renin, potassium, and sodium levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal Function</measure>
    <time_frame>One week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Urea and creatinine in urine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C reactive protein</measure>
    <time_frame>One week</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Lasilactone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dosage form: One capsule taking in the morning Dosage: furosemide, 20mg, and spironolactone, 100 mg. Frequency and duration: One capsule daily for 7 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sodium-Restricted Diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Recommendations to follow Sodium-Restricted Diet duration: one week</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lasilactone</intervention_name>
    <arm_group_label>Lasilactone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sodium-Restricted Diet</intervention_name>
    <arm_group_label>Sodium-Restricted Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe OSA with apnea-hypopnea index (AHI)&gt;= 30/h

          -  Body mass index = 19-34,9 kg/m2

          -  Caucasians

        Exclusion Criteria:

          -  Use of CPAP

          -  Systemic arterial hypertension

          -  Established cardiovascular disease (myocardial infarction)

          -  Stroke

          -  Heart failure

          -  Presence of tonsillar hypertrophy.

          -  Use of more than one drug for hypertension

          -  Secondary hypertension

          -  Participation in other clinical trial in previous 6 months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denis Martinez, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cintia Fiori, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Rio Grande do Sul</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cintia Fiori, MSc</last_name>
    <phone>555133598289</phone>
    <email>cintiazfiori@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de Clinicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035-903</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cintia Zappe Fiori, MSc</last_name>
      <phone>555133598289</phone>
      <email>cintiazfiori@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Cintia Z Fiori, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>March 19, 2014</lastchanged_date>
  <firstreceived_date>September 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep apnea</keyword>
  <keyword>Treatment</keyword>
  <keyword>Sodium-Restricted Diet</keyword>
  <keyword>Diuretic</keyword>
  <keyword>Lasilactone</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diuretics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
